BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7939409)

  • 21. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular basis of a selective C1s deficiency associated with early onset multiple autoimmune diseases.
    Dragon-Durey MA; Quartier P; Frémeaux-Bacchi V; Blouin J; de Barace C; Prieur AM; Weiss L; Fridman WH
    J Immunol; 2001 Jun; 166(12):7612-6. PubMed ID: 11390518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of the fluid-phase proteolytic cleavage of human complement subcomponents C4 and C2 by C1s and C1r2-C1s2.
    Thielens NM; Villiers CL; Villiers MB; Colomb MG
    FEBS Lett; 1984 Jan; 165(1):111-6. PubMed ID: 6319179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective analysis of C1 dissociation and complement activation in patients with systemic lupus erythematosus.
    Jonsson H; Sturfelt G; Mårtensson U; Truedsson L; Sjöholm AG
    Clin Exp Rheumatol; 1995; 13(5):573-80. PubMed ID: 8575134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inherited complement deficiency states and SLE.
    Rynes RI
    Clin Rheum Dis; 1982 Apr; 8(1):29-47. PubMed ID: 6288318
    [No Abstract]   [Full Text] [Related]  

  • 26. Human genes for complement components C1r and C1s in a close tail-to-tail arrangement.
    Kusumoto H; Hirosawa S; Salier JP; Hagen FS; Kurachi K
    Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7307-11. PubMed ID: 2459702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trimer and tetramer complexes containing C1 esterase inhibitor, C1r and C1s, in serum and synovial fluid of patients with rheumatic disease.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol Methods; 1990 May; 129(1):55-61. PubMed ID: 2338498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
    Katz Y; Strunk RC
    J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of the synthesis of C1 subcomponents and C1-inhibitor.
    Gulati P; Lemercier C; Guc D; Lappin D; Whaley K
    Behring Inst Mitt; 1993 Dec; (93):196-203. PubMed ID: 8172568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deficiency of serum C1 subcomponents and low functional activity of C1- inhibitor in a patient with urticaria and cryoglobulinemia.
    Lamas AM; Arnold PI; Schultz DR
    Am J Med; 1992 Apr; 92(4):445-6. PubMed ID: 1558093
    [No Abstract]   [Full Text] [Related]  

  • 31. Biosynthesis of C1r and C1s subcomponents.
    Drouet C; Reboul A
    Behring Inst Mitt; 1989 Jul; (84):80-8. PubMed ID: 2552984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assignment of the complement serine protease genes C1r and C1s to chromosome 12 region 12p13.
    Nguyen VC; Tosi M; Gross MS; Cohen-Haguenauer O; Jegou-Foubert C; de Tand MF; Meo T; Frézal J
    Hum Genet; 1988 Apr; 78(4):363-8. PubMed ID: 2834284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus.
    Lockshin MD; Qamar T; Redecha P; Harpel PC
    Arthritis Rheum; 1986 Dec; 29(12):1467-72. PubMed ID: 3492208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement C1s as a diagnostic marker and therapeutic target: Progress and propective.
    Ye J; Yang P; Yang Y; Xia S
    Front Immunol; 2022; 13():1015128. PubMed ID: 36275687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inherited disorders of complement.
    Guenther LC
    J Am Acad Dermatol; 1983 Dec; 9(6):815-39. PubMed ID: 6315788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.
    Ghebrehiwet B; Randazzo BP; Dunn JT; Silverberg M; Kaplan AP
    J Clin Invest; 1983 May; 71(5):1450-6. PubMed ID: 6304147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement components C1q, C1r/C1s, and C1INH in rheumatoid arthritis. Correlation of in situ hybridization and northern blot results with function and protein concentration in synovium and primary cell cultures.
    Breitner S; Störkel S; Reichel W; Loos M
    Arthritis Rheum; 1995 Apr; 38(4):492-8. PubMed ID: 7718002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of rock bream (Oplegnathus fasciatus) complement components C1r and C1s in terms of molecular aspects, genomic modulation, and immune responsive transcriptional profiles following bacterial and viral pathogen exposure.
    Godahewa GI; Bathige SD; Herath HM; Noh JK; Lee J
    Fish Shellfish Immunol; 2015 Oct; 46(2):656-68. PubMed ID: 26241508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical hypocomplementemic vasculitis syndrome in a child.
    Waldo FB; Leist PA; Strife CF; Forristal J; West CD
    J Pediatr; 1985 May; 106(5):745-50. PubMed ID: 2987470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
    Thielens NM; Illy C; Bally IM; Arlaud GJ
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.